Aneeza Kim

730 total citations
10 papers, 520 citations indexed

About

Aneeza Kim is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Aneeza Kim has authored 10 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Neurology. Recurrent topics in Aneeza Kim's work include Parkinson's Disease Mechanisms and Treatments (3 papers), Genetic Neurodegenerative Diseases (3 papers) and Nuclear Receptors and Signaling (2 papers). Aneeza Kim is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (3 papers), Genetic Neurodegenerative Diseases (3 papers) and Nuclear Receptors and Signaling (2 papers). Aneeza Kim collaborates with scholars based in United States and Canada. Aneeza Kim's co-authors include Eric E. Swayze, Holly Kordasiewicz, Hien Zhao, Gene Hung, Andrew B. West, Andreas Weihofen, Laura A. Volpicelli‐Daley, Vedad Delic, C. Frank Bennett and Sagar Damle and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Annals of Neurology.

In The Last Decade

Aneeza Kim

10 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aneeza Kim United States	6	314	246	179	72	56	10	520
Uri Nimrod Ramírez-Jarquín Mexico	10	278 0.9×	149 0.6×	146 0.8×	77 1.1×	39 0.7×	14	480
Yasuto Itoyama Japan	11	106 0.3×	147 0.6×	185 1.0×	43 0.6×	111 2.0×	13	611
Zoe Siemienski United States	8	214 0.7×	100 0.4×	119 0.7×	63 0.9×	88 1.6×	9	390
Inga Hansson Sweden	8	139 0.4×	81 0.3×	68 0.4×	59 0.8×	36 0.6×	8	322
Dorothée Bleckmann Switzerland	8	228 0.7×	172 0.7×	81 0.5×	17 0.2×	31 0.6×	9	334
Yujiro Higuchi Japan	13	206 0.7×	381 1.5×	135 0.8×	41 0.6×	161 2.9×	53	551
Himesha Vandebona Australia	8	136 0.4×	106 0.4×	133 0.7×	20 0.3×	72 1.3×	13	287
Kishin Koh Japan	11	136 0.4×	194 0.8×	72 0.4×	64 0.9×	99 1.8×	38	295
Marie‐Céline Fleury France	13	242 0.8×	207 0.8×	157 0.9×	34 0.5×	61 1.1×	21	498

Countries citing papers authored by Aneeza Kim

Since Specialization

Citations

This map shows the geographic impact of Aneeza Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aneeza Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aneeza Kim more than expected).

Fields of papers citing papers by Aneeza Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aneeza Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aneeza Kim. The network helps show where Aneeza Kim may publish in the future.

Co-authorship network of co-authors of Aneeza Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Aneeza Kim. A scholar is included among the top collaborators of Aneeza Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aneeza Kim. Aneeza Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Zhao, Hien, Neena S. John, Vedad Delic, et al.. (2021). LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson’s Disease Mouse Model. Molecular Therapy — Nucleic Acids. 24. 1051–1053. 2 indexed citations

2.

Zhao, Hien, Neena S. John, Vedad Delic, et al.. (2021). LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson’s Disease Mouse Model. Molecular Therapy — Nucleic Acids. 25. 152–154. 3 indexed citations

3.

Kim, Aneeza, Laryssa A. Huryn, Edith Lopez, et al.. (2018). Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7. Science Translational Medicine. 10(465). 54 indexed citations

4.

Zhao, Hien, Vedad Delic, Aneeza Kim, et al.. (2017). LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson’s Disease Mouse Model. Molecular Therapy — Nucleic Acids. 8. 508–519. 155 indexed citations

5.

Hagemann, Tracy L., Berit Powers, Curt Mazur, et al.. (2017). Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander disease. Annals of Neurology. 83(1). 27–39. 54 indexed citations

6.

Zhao, Hien, Sagar Damle, Steven Kuntz, et al.. (2017). PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models. Journal of Clinical Investigation. 128(1). 359–368. 112 indexed citations

7.

Billioud, Gaëtan, Robert L. Kruse, Melissa Carrillo, et al.. (2015). In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides. Journal of Hepatology. 64(4). 781–789. 42 indexed citations

8.

Pandey, Sanjay K., Thurman M. Wheeler, Aneeza Kim, et al.. (2015). Identification and Characterization of Modified Antisense Oligonucleotides Targeting DMPK in Mice and Nonhuman Primates for the Treatment of Myotonic Dystrophy Type 1. Journal of Pharmacology and Experimental Therapeutics. 355(2). 329–340. 93 indexed citations

9.

Peralta, Raechel, Audrey Low, Sheri Booten, et al.. (2014). Targeting KLF1 for the Treatment of Sickle Cell Disease Using Antisense Oligonucleotides. Blood. 124(21). 4038–4038. 1 indexed citations

10.

Peralta, Raechel, Audrey Low, Aneeza Kim, et al.. (2013). Targeting BCL11A and KLF1 For The Treatment Of Sickle Cell Disease and β-Thalassemia In Vitro using Antisense Oligonucleotides. Blood. 122(21). 1022–1022. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact